A. Guastadisegni

632 total citations
10 papers, 504 citations indexed

About

A. Guastadisegni is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, A. Guastadisegni has authored 10 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 8 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in A. Guastadisegni's work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). A. Guastadisegni is often cited by papers focused on Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (7 papers) and Liver Disease Diagnosis and Treatment (5 papers). A. Guastadisegni collaborates with scholars based in Italy and France. A. Guastadisegni's co-authors include Giuseppe Pastore, Michele Mazzola, Teresa Santantonio, T. Santantonio, Tiziana Iacovazzi, Antonio Miglietta, C Casalino, Gioacchino Leandro, M. Fasano and Ruggiero Francavilla and has published in prestigious journals such as Hepatology, Journal of Hepatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

A. Guastadisegni

10 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Guastadisegni Italy 5 487 477 63 14 13 10 504
Beatriz Calle Serrano Germany 7 561 1.2× 568 1.2× 51 0.8× 9 0.6× 24 1.8× 9 605
J Cianciara Poland 10 289 0.6× 289 0.6× 50 0.8× 8 0.6× 18 1.4× 35 328
C. Mayerat Switzerland 7 317 0.7× 314 0.7× 36 0.6× 6 0.4× 10 0.8× 9 354
Lubna Ghanem Denmark 7 317 0.7× 284 0.6× 93 1.5× 10 0.7× 8 0.6× 7 344
Watcharasak Chotiyaputta Thailand 13 546 1.1× 555 1.2× 106 1.7× 13 0.9× 15 1.2× 30 623
Satomi Iwasaki Japan 13 458 0.9× 436 0.9× 91 1.4× 69 4.9× 5 0.4× 22 519
Bandita Parhy United States 10 463 1.0× 447 0.9× 110 1.7× 10 0.7× 7 0.5× 12 530
Naofumi Ohno Japan 8 383 0.8× 398 0.8× 29 0.5× 6 0.4× 4 0.3× 12 426
Vithika Suri United States 9 263 0.5× 264 0.6× 52 0.8× 6 0.4× 9 0.7× 40 350
Karl‐Georg Simon Germany 11 519 1.1× 515 1.1× 85 1.3× 13 0.9× 8 0.6× 33 550

Countries citing papers authored by A. Guastadisegni

Since Specialization
Citations

This map shows the geographic impact of A. Guastadisegni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Guastadisegni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Guastadisegni more than expected).

Fields of papers citing papers by A. Guastadisegni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Guastadisegni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Guastadisegni. The network helps show where A. Guastadisegni may publish in the future.

Co-authorship network of co-authors of A. Guastadisegni

This figure shows the co-authorship network connecting the top 25 collaborators of A. Guastadisegni. A scholar is included among the top collaborators of A. Guastadisegni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Guastadisegni. A. Guastadisegni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Santantonio, Teresa, M. Fasano, S. Durantel, et al.. (2009). Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B. Antiviral Therapy. 14(4). 557–565. 24 indexed citations
2.
Santantonio, Teresa, M. Fasano, A. Guastadisegni, et al.. (2004). Efficacy of a 24-week course of PEG-interferon α-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance. Journal of Hepatology. 42(3). 329–333. 110 indexed citations
3.
Santantonio, Teresa, A. Guastadisegni, C Casalino, et al.. (2004). 510 Efficacy of Peg-interferon alpha-2B (Pegintron) monotherapy in acute hepatitis C: A preliminary analysis. Journal of Hepatology. 40. 150–150. 1 indexed citations
4.
Santantonio, Teresa, A. Guastadisegni, C Casalino, et al.. (2003). Natural course of acute hepatitis C: a long-term prospective study. Digestive and Liver Disease. 35(2). 104–113. 75 indexed citations
5.
Niro, Grazia Anna, Teresa Santantonio, Rosanna Fontana, et al.. (2003). Re‐treatment of patients with anti‐HBe‐positive chronic hepatitis B who relapsed after an initial course of lamivudine. Alimentary Pharmacology & Therapeutics. 18(9). 933–940. 4 indexed citations
6.
Guastadisegni, A., et al.. (2003). 1007 Successful treatment of acute hepatitis C with alpha 2B PEG-interferon monotherapy: an interim analysis. Hepatology. 38. 642–642. 1 indexed citations
7.
Santantonio, Teresa, Grazia Anna Niro, Gioacchino Leandro, et al.. (2002). Lamivudine/interferon combination therapy in anti-HBe positive chronic hepatitis B patients: a controlled pilot study. Journal of Hepatology. 36(6). 799–804. 87 indexed citations
8.
Santantonio, Teresa, et al.. (2002). Lamivudine-resistant HBV mutants in patients with anti-HBe positive chronic hepatitis B treated with long-term lamivudine monotherapy. Journal of Hepatology. 36. 127–128. 1 indexed citations
9.
Santantonio, Teresa, et al.. (2001). Long-term lamivudine treatment in anti-HBe positive chronic hepatitis B: an interim analysis. Journal of Hepatology. 34. 132–133. 3 indexed citations
10.
Santantonio, T., Michele Mazzola, Tiziana Iacovazzi, et al.. (2000). Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine. Journal of Hepatology. 32(2). 300–306. 198 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatriz Calle Serrano Breakdown of academic impact, for papers by J Cianciara Breakdown of academic impact, for papers by C. Mayerat Breakdown of academic impact, for papers by Lubna Ghanem Breakdown of academic impact, for papers by Watcharasak Chotiyaputta Breakdown of academic impact, for papers by Satomi Iwasaki Breakdown of academic impact, for papers by Bandita Parhy Breakdown of academic impact, for papers by Naofumi Ohno Breakdown of academic impact, for papers by Vithika Suri Breakdown of academic impact, for papers by Karl‐Georg Simon
Rankless by CCL
2026